Agilent Automated Workflows at SLAS2025: Connecting with Confidence
Agilent Technologies (NYSE: A) will showcase new automated laboratory workflow solutions at SLAS2025 International Conference & Exhibition in San Diego from January 25-29. The company is focusing on advancing automation solutions to optimize lab performance, efficiency, and reproducibility across research, drug discovery, development, and manufacturing processes.
The automation solutions cover sample preparation, auto dilution, sample delivery, and washout across various applications including cell analysis, genomics, proteomics, biomolecule analysis, and mass spectrometry. Key innovations to be showcased include the NovoCyte Opteon Spectral Flow Cytometer, SureSelect Cancer CGP Assay, ePrep Partnership for GC/MS and LC/MS analyses, and Avida for DNA sequencing.
The company will participate in a Solutions Spotlight Presentation on viral infectivity assays and a roundtable discussion about robotic automation in future laboratories. Agilent serves as a Diamond Sponsor of the event.
Agilent Technologies (NYSE: A) presenterà nuove soluzioni automatizzate per il flusso di lavoro di laboratorio alla SLAS2025 International Conference & Exhibition a San Diego dal 25 al 29 gennaio. L'azienda si concentra sull'avanzamento delle soluzioni di automazione per ottimizzare le prestazioni, l'efficienza e la riproducibilità dei laboratori in ambito di ricerca, scoperta di farmaci, sviluppo e processi di produzione.
Le soluzioni di automazione riguardano la preparazione dei campioni, l'auto diluizione, la consegna dei campioni e il risciacquo in diverse applicazioni, tra cui analisi cellulare, genomica, proteomica, analisi di biomolecole e spettrometria di massa. Le innovazioni chiave che verranno presentate includono il NovoCyte Opteon Spectral Flow Cytometer, il SureSelect Cancer CGP Assay, la partnership ePrep per le analisi GC/MS e LC/MS, e Avida per il sequenziamento del DNA.
L'azienda parteciperà a una presentazione focalizzata sulle soluzioni relative ai saggi di infettività virale e a una tavola rotonda sulle automazioni robotiche nei laboratori del futuro. Agilent è uno sponsor Diamond dell'evento.
Agilent Technologies (NYSE: A) presentará nuevas soluciones automatizadas para flujos de trabajo de laboratorio en la SLAS2025 International Conference & Exhibition en San Diego del 25 al 29 de enero. La empresa se centra en avanzar en soluciones de automatización para optimizar el rendimiento, la eficiencia y la reproducibilidad del laboratorio en investigación, descubrimiento de fármacos, desarrollo y procesos de fabricación.
Las soluciones de automatización abarcan la preparación de muestras, la auto dilución, la entrega de muestras y el lavado en diversas aplicaciones, incluidas análisis celular, genómica, proteómica, análisis de biomoléculas y espectrometría de masas. Las innovaciones clave que se mostrarán incluyen el NovoCyte Opteon Spectral Flow Cytometer, el SureSelect Cancer CGP Assay, la asociación ePrep para análisis de GC/MS y LC/MS, y Avida para secuenciación de ADN.
La empresa participará en una presentación de soluciones sobre ensayos de infectividad viral y en una mesa redonda sobre automatización robótica en futuros laboratorios. Agilent actúa como patrocinador Diamond del evento.
Agilent Technologies (NYSE: A)는 1월 25일부터 29일까지 샌디에이고에서 열리는 SLAS2025 국제 컨퍼런스 및 전시회에서 새로운 자동화 실험실 워크플로우 솔루션을 선보일 예정입니다. 이 회사는 연구, 약물 발견, 개발 및 제조 프로세스 전반에 걸쳐 실험실 성능, 효율성 및 재현 가능성을 최적화하기 위한 자동화 솔루션의 발전에 중점을 두고 있습니다.
자동화 솔루션은 샘플 준비, 자동 희석, 샘플 전달 및 세척을 포함하며, 세포 분석, 유전체학, 단백질체학, 바이오 분자 분석 및 질량 분석과 같은 다양한 응용 분야에서 적용됩니다. 주요 혁신으로는 NovoCyte Opteon 스펙트럼 유세포 분석기, SureSelect Cancer CGP Assay, GC/MS 및 LC/MS 분석을 위한 ePrep 파트너십, 그리고 DNA 염기서열 분석을 위한 Avida가 있습니다.
회사는 바이러스 감염성 분석에 관한 솔루션 스포트라이트 발표 및 미래 실험실의 로봇 자동화에 대한 원탁 토론에 참여할 예정입니다. Agilent는 이 행사에서 Diamond 스폰서로 활동합니다.
Agilent Technologies (NYSE: A) présentera de nouvelles solutions de flux de travail de laboratoire automatisées lors de la SLAS2025 International Conference & Exhibition à San Diego du 25 au 29 janvier. L'entreprise se concentre sur l'avancement des solutions d'automatisation pour optimiser la performance, l'efficacité et la reproductibilité des laboratoires dans les domaines de la recherche, de la découverte de médicaments, du développement et des processus de fabrication.
Les solutions d'automatisation incluent la préparation des échantillons, la dilution automatisée, la livraison d'échantillons et le nettoyage à travers diverses applications, y compris l'analyse cellulaire, la génomique, la protéomique, l'analyse des biomolécules et la spectrométrie de masse. Les innovations clés qui seront présentées comprennent le NovoCyte Opteon Spectral Flow Cytometer, le SureSelect Cancer CGP Assay, le partenariat ePrep pour les analyses GC/MS et LC/MS, et Avida pour le séquençage de l'ADN.
L'entreprise participera à une présentation Solutions Spotlight sur les essais d'infectivité virale et à une table ronde sur l'automatisation robotisée dans les futurs laboratoires. Agilent est un sponsor Diamond de l'événement.
Agilent Technologies (NYSE: A) wird auf der SLAS2025 International Conference & Exhibition in San Diego vom 25. bis 29. Januar neue automatisierte Laborworkflow-Lösungen präsentieren. Das Unternehmen konzentriert sich darauf, Automatisierungslösungen voranzutreiben, um die Leistung, Effizienz und Reproduzierbarkeit von Laboren in Forschung, Arzneimittelentdeckung, Entwicklung und Fertigungsprozessen zu optimieren.
Die Automatisierungslösungen umfassen die Probenvorbereitung, Auto-Dilution, Probenanlieferung und Auswaschvorgänge in verschiedenen Anwendungen, einschließlich Zellanalysen, Genomik, Proteomik, Biomolekülanalysen und Massenspektrometrie. Wesentliche Innovationen, die gezeigt werden, umfassen das NovoCyte Opteon Spectral Flow Cytometer, den SureSelect Cancer CGP Assay, die ePrep-Partnerschaft für GC/MS- und LC/MS-Analysen sowie Avida für die DNA-Sequenzierung.
Das Unternehmen wird an einer Solutions Spotlight Präsentation zu Assays der viralen Infektiosität und einer Diskussionsrunde über robotergestützte Automatisierung in zukünftigen Laboren teilnehmen. Agilent fungiert als Diamond-Sponsor der Veranstaltung.
- Expanding automation solutions portfolio across multiple laboratory applications
- Strategic partnership with ePrep for GC/MS and LC/MS workflow solutions
- Launch of advanced products including NovoCyte Opteon with up to 5 lasers and 73 detectors
- None.
Building the lab of the future today by enhancing lab productivity with robust and reliable automation technology
Automation is becoming increasingly critical for labs as they navigate the competitive landscape. Agilent's automation solutions include sample and standard preparation, auto dilution, sample delivery, and washout. These solutions cover cell analysis, genomics, proteomics, biomolecule analysis, and mass spectrometry in regulated and non-regulated labs. By automating these tasks, scientists and lab technicians can focus on more important work. Automated sample preparation becomes more manageable, accurate, and consistent, which increases data quality and reduces the time needed to get results, ultimately leading to better decisions.
“Connecting automated solutions to your workflows allows for current manual processes to be a thing of the past, significantly boosting lab productivity, making lab managers’ days easier and giving back time to focus on other tasks,” stated Lars Kristiansen, general manager of Agilent’s Automation Solutions Business. “SLAS is the perfect platform for us to showcase how our cutting-edge automation solutions push the boundaries of what's possible. We're dedicated to delivering innovative workflow solutions that advance automation and drive customer success.”
SLAS attendees are invited to visit exhibit booth #1529 to discover how Agilent's automation solutions can confidently connect and enhance their labs. Highlighted innovations will include:
- NovoCyte Opteon Spectral Flow Cytometer ‒ The NovoCyte Opteon boasts up to 5 lasers and 73 detectors, a proprietary optics design, and advanced electronics, enabling it to deliver data with high resolution and sensitivity.
- SureSelect Cancer CGP Assay ‒ The SureSelect Cancer CGP Assay offers comprehensive genomic profiling for solid tumors, detecting various somatic variants and immuno-oncology biomarkers.
- ePrep Partnership ‒ Agilent has partnered with ePrep to offer streamlined end-to-end workflow solutions for GC/MS and LC/MS analyses.
- Avida ‒ Agilent Avida offers high-performance target enrichment for DNA sequencing, optimized for sensitive variant detection and streamlined workflows.
A Solutions Spotlight Presentation “Revolutionizing Viral Infectivity Assays: High-Resolution Automated Cell Imaging Meets AI/ML Analysis” will be held Monday, January 27, from 11:30 AM - 11:50 AM PT in the SLAS Solutions Spotlight Theater (Booth #2907) highlighting the Agilent BioTek Cytation platform. Presenters include Ilya Goldberg, Ph.D., Chief Scientific Officer at ViQi, and Joe Clayton, Ph.D., Director of Application Development and Technical Marketing, in the Cell Analysis Division at Agilent.
Additionally Agilent will participate in a roundtable discussion entitled “Robotic automation is the gateway to the Lab of the Future,” hosted by ABB Robotics. The conversation will highlight how robots can unlock new possibilities in the lab, and explore some of the challenges that can be solved using robots. The roundtable will be held on Tuesday, January 28, from 8:30 AM - 10:00 AM PT in Room #26A at the conference venue, and is open to all SLAS attendees.
Agilent is a proud Diamond Sponsor of the SLAS2025 International Conference & Exhibition, highlighting Agilent's commitment to advancing laboratory automation and life sciences discovery.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of
View source version on businesswire.com: https://www.businesswire.com/news/home/20250124528121/en/
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
Source: Agilent Technologies Inc.
FAQ
What new products is Agilent (NYSE: A) showcasing at SLAS2025?
When and where is Agilent presenting at SLAS2025?
What are the key features of Agilent's NovoCyte Opteon Flow Cytometer?
How is Agilent (A) advancing laboratory automation in 2025?
